Condition
Hydroxychloroquine Retinopathy
Total Trials
3
Recruiting
2
Active
2
Completed
0
Key Insights
Highlights
No notable highlights available yet
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 50/100
Termination Rate
0.0%
0 terminated out of 3 trials
Late-Stage Pipeline
0%
0 trials in Phase 3/4
Results Transparency
0%
0 of 0 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Recruiting2
Not Yet Recruiting1
Clinical Trials (3)
Showing 3 of 3 trials
NCT07409740Not Yet RecruitingPrimary
Optical Coherence Tomography Angiography Evaluation Of Patients Taking Hydroxychloroquine
NCT06035887RecruitingPrimary
Novel ERG for Detection of Hydroxychloroquine Retinopathy
NCT05355415Recruiting
Adaptive Optics Imaging of Outer Retinal Diseases
Showing all 3 trials